Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery

• Status: Unknown status
• Trial end date: 2020-03-30
• Target enrollment: 0
• Participant gender: All

Summary

This study aim at determining the efficacy of Nepafenac and Ketorolac in obtaining adequate intraoperative mydriasis and preventing miosis during cataract surgery. It also compare the efficacy of both Nepafenac versus Ketorolac, and determine the more effective agent in preventing miosis during cataract surgery. The investigators try to determine if the effect of preoperative NSAIDs agents use would show a financial benefit, or this manoeuvre would add a financial load on the patients who are candidate for cataract surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assiut University
• Treatments: Cyclopentolate; Ketorolac; Ketorolac Tromethamine; Nepafenac; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Patients with cataract who are candidate for cataract surgery

Exclusion Criteria:

• D.M,

• Patient with other ocular comorbidities rather than cataract,

• Patients with history of trauma.

• Patients on Corticosteroid drops treatment.

• Previous intraocular surgery.